Mergers and Acquisitions

Kersia, a portfolio company of French institutional investor Ardian, in its acquisition of Choisy Laboratories

Kersia
Key Contact
Niko Veilleux

Partner, Corporate, Montréal

Team
Sophie Amyot

Partner, Corporate, Montréal

Daniel Stysis

Associate, Corporate, Montréal

On July 18, 2019, Kersia announced the acquisition of Choisy Laboratories for an undisclosed value. This transaction expands Kersia’s geographical footprint in North America, allowing the company to expand its presence in new sub-segments and to acquire new technologies; it has been completed with the support of Ardian, its majority shareholder. This is Kersia’s fifth strategic acquisition since its acquisition by Ardian in October 2016.

Choisy Laboratories is Quebec-based developer and manufacturer of chemical, biotechnological and biosecurity hygiene solutions, from the Trudeau family and Champlain Financial Corporation.

Ardian is a world-leading private investment house with assets of US$96 billion managed or advised in Europe, the Americas and Asia.

Kersia is a global leader in biosecurity and food safety with value added products and solutions to prevent diseases or contamination in both animal and humans at every stage of the food supply chain.

Osler, Hoskin & Harcourt LLP advised Kersia and Ardian with a team consisting of Niko Veilleux, Daniel Stysis, and Sophie Amyot (Corporate).

Value
-
Date Closed
July 18, 2019
Lead Office
Montréal
Key Contact
Niko Veilleux

Partner, Corporate, Montréal

Team
Sophie Amyot

Partner, Corporate, Montréal

Daniel Stysis

Associate, Corporate, Montréal